Owlet (OWLTW) Cash from Financing Activities (2020 - 2026)
Owlet (OWLTW) reported Cash from Financing Activities of $5.5 million for Q1 2026, up 171.2% year-over-year from $2.0 million in Q1 2025, and down 69.47% on a QoQ basis from $17.9 million in Q4 2025.
Owlet (OWLTW) has 7 years of Cash from Financing Activities data on file, last reported at $5.5 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 171.2% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.6 million (up 177.29% YoY) and the FY2025 annual result came in at $32.1 million, up 100.17% from the prior year.
- Cash from Financing Activities declined to $5.5 million in Q1 2026 per OWLTW's latest filing, from $17.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $22.9 million in Q1 2023 and bottomed at -$4.4 million in Q3 2023.
- The 5-year median for Cash from Financing Activities is $3.0 million (2023), against an average of $4.8 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities sank 321.79%; it then surged 2033.42% in 2025.
- Tracing OWLTW's Cash from Financing Activities over 5 years: stood at -$2.0 million in 2022, then soared by 253.22% to $3.0 million in 2023, then sank by 236.24% to -$4.1 million in 2024, then jumped by 538.21% to $17.9 million in 2025, then slumped by 69.47% to $5.5 million in 2026.
- Per Business Quant, the three latest OWLTW Cash from Financing Activities figures stand at $5.5 million (Q1 2026), $17.9 million (Q4 2025), and $4.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Owlet | - | - | 12.24 Mn | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.46 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Sep 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Jun 30, 2025 | 7.85 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Sep 30, 2024 | 14.53 Mn |
| Jun 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 368,000.00 |
| Mar 31, 2024 | 5.23 Mn |
| Mar 31, 2024 | 5.23 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | -4.38 Mn |
| Sep 30, 2023 | -4.38 Mn |
| Jun 30, 2023 | 7.38 Mn |
| Jun 30, 2023 | 7.38 Mn |
| Mar 31, 2023 | 22.92 Mn |
| Mar 31, 2023 | 22.92 Mn |
| Dec 31, 2022 | -1.96 Mn |
| Dec 31, 2022 | -1.96 Mn |
| Sep 30, 2022 | 1.97 Mn |
| Sep 30, 2022 | 1.97 Mn |
| Jun 30, 2022 | -2.67 Mn |
| Jun 30, 2022 | -2.67 Mn |
| Mar 31, 2022 | 1.78 Mn |
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | -13.53 Mn |
| Dec 31, 2021 | -13.53 Mn |
| Sep 30, 2021 | 122.62 Mn |
| Sep 30, 2021 | 122.62 Mn |
| Jun 30, 2021 | 8.72 Mn |
| Jun 30, 2021 | 8.72 Mn |
| Mar 31, 2021 | 2.81 Mn |
| Mar 31, 2021 | 2.81 Mn |
| Dec 31, 2020 | 231.74 Mn |
| Dec 31, 2020 | 231.74 Mn |
| Sep 30, 2020 | 231.76 Mn |
| Sep 30, 2020 | 231.76 Mn |
| Jun 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 25,000.00 |